COYA
Coya Therapeutics, Inc.
4.90$
+0.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -37.3% | 1,691.8% | -133.2% | – | -123,451.2% | -1,096.7% | -3,528.6% | -31.7% | -25.4% | -2,472.1% | -5,610,076.7% | -170,624.5% | |
| – | 0.1% | 5.4% | 0.2% | – | 350.4% | 2.7% | 4.2% | 0.2% | 0.2% | 1.1% | 2,302.1% | 70.2% | |
| – | 4.0% | 343.5% | 19.3% | – | 40,499.4% | 418.8% | 633.0% | 30.0% | 27.9% | 874.2% | 1,287,095.7% | 39,176.3% | |
| – | -65.7% | 5,306.2% | -68.3% | – | -14,927.3% | 1,315.1% | -440.6% | -17.1% | 45.9% | -481.7% | -38,907.1% | -1,182.6% | |
| – | 0.0% | 19.7% | 0.0% | – | 0.2% | 19.4% | 0.0% | 0.0% | 0.0% | 0.0% | 363.1% | 11.0% | |
| – | -3.2% | -19.7% | – | – | – | -9,684.6% | – | -14.5% | -16.4% | -352.4% | -363,400.7% | -11,071.3% | |
| – | 402.8% | 979.0% | 150.3% | – | 496,523.3% | 7.4% | 0.0% | 0.5% | 513.9% | 4,378.1% | 8,927,744.7% | 271,753.3% | |
| – | 362.2% | 2,651.1% | 17.1% | – | 373,072.1% | -1,089.3% | -3,528.6% | -45.7% | 472.0% | 1,553.6% | 2,954,267.3% | 90,057.6% | |
| – | -37.3% | 1,691.8% | -133.2% | – | -123,451.2% | -1,096.7% | -3,528.6% | -31.7% | -25.4% | -2,472.1% | -5,609,713.6% | -170,613.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.